J. David Joyner - Apr 1, 2025 Form 4/A - Amendment Insider Report for CVS HEALTH Corp (CVS)

Role: President and CEO, Director
Signature: /s/ J. David Joyner
Stock symbol: CVS
Transactions as of: Apr 1, 2025
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 5/9/2025, 04:32 PM
Date Of Original Report: Apr 3, 2025
Previous filing: Mar 3, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Joyner J. David	President and CEO, Director	ONE CVS DRIVE, WOONSOCKET	/s/ J. David Joyner	2025-05-09	0001515598

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock (RSUs)	Award	$0	+53.3K	+182.67%	$0.00	82.5K	Apr 1, 2025	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purpose of this amendment is to correct the number and type of derivative securities granted to the reporting person on April 1, 2025, which was originally reported on a Form 4 filed on April 3, 2025 (the "Initial Form 4"). The Initial Form 4 incorrectly reported that the reporting person was granted stock options. As reported in this amendment, the reporting person was granted 53,324 restricted stock units ("RSUs"), awarded pursuant to Issuer's 2017 Incentive Compensation Plan, and not 226,138 stock options, as reported in the Initial Form 4. Restrictions on the RSUs lapse in four equal annual installments, commencing 4/1/2026.

Content

The purpose of this amendment is to correct the number and type of derivative securities granted to the reporting person on April 1, 2025, which was originally reported on a Form 4 filed on April 3, 2025 (the "Initial Form 4"). The Initial Form 4 incorrectly reported that the reporting person was granted stock options. As reported in this amendment, the reporting person was granted 53,324 restricted stock units ("RSUs"), awarded pursuant to Issuer's 2017 Incentive Compensation Plan, and not 226,138 stock options, as reported in the Initial Form 4. Restrictions on the RSUs lapse in four equal annual installments, commencing 4/1/2026.